GGrantIndex
Sort

261,768 grants matching gene therapy

Longitudinal Epigenomic Tracking of the Reprogramming Process

$2,217,607
Michael P Snyder · Stanford University · P01 · FY2013 · GM

Optimization of SHIP1 Inhibitors for the Treatment of Alzheimer's Disease

$2,217,438
Timothy I Richardson · Indiana University Indianapolis · U01 · FY2025 · AG

Gene Therapy For Cystic Fibrosis Lung Disease

$2,216,878
Paul B McCray · University Of Iowa · P01 · FY2015 · HL

Neuroblastoma Biology and Therapy

$2,216,467
Garrett M Brodeur · Children'S Hosp Of Philadelphia · P01 · FY2007 · CA

CCR Genomics Core

$2,216,316
Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA

Colon Cancer Family Registry Cohort

$2,216,188
Robert William Haile · Stanford University · UM1 · FY2014 · CA

Stem Cell Gene Therapy for Hemoglobinopathies

$2,215,800
George Stamatoyannopoulos · University Of Washington · P01 · FY2007 · HL

DNA Methylation & Chromatin Modifications: Mechanisms & Applications in Cancer*

$2,215,284
Samson T Jacob · Ohio State University · P01 · FY2007 · CA

Translational Platform for Epilepsy Therapy and Biomarker Discovery

$2,215,256
Aristea S Galanopoulou · Albert Einstein College Of Medicine · R01 · FY2024 · NS

Identifying the gene networks of insulin resistance: the GENESIPS study

$2,214,717
Thomas None Quertermous · Stanford University · U01 · FY2013 · HL

Proteogenomics for Organ Transplantation: Prediction, Diagnosis, Intervention

$2,214,645
Michael Abecassis · Northwestern University At Chicago · U01 · FY2009 · AI

Stem Cell Gene Therapy for Hemoglobinopathies

$2,214,612
University Of Washington · P01 · FY2005 · HL

Tolerability of SRX246 in Huntington's Disease Patients

$2,214,354
Michael J Brownstein · Azevan Pharmaceuticals, Inc. · U44 · FY2016 · NS

SPORE in Gastrointestinal Cancer

$2,213,973
Joel E Tepper · Univ Of North Carolina Chapel Hill · P50 · FY2006 · CA

Neurobiology of Substance Abuse & Addiction - Preclinical Studies

$2,213,543
Nora D. Volkow · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA

Chronic Rhinosinusitis Integrative Studies Program (CRISP)

$2,213,488
Robert P Schleimer · Northwestern University At Chicago · U19 · FY2016 · AI

GENERAL CLINICAL RESEARCH CENTER

$2,213,394
University Of Alabama At Birmingham · M01 · FY2002 · RR

Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease

$2,213,189
Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Identification of Genes Causing Syndromic and Nonsyndromic Hearing Impairment

$2,213,054
Thomas Friedman · National Institute On Deafness And Other Communication Disorders · ZIA · FY2025 · DC

Functional Studies of "Deafness Genes" Essential for Hearing

$2,213,054
Thomas Friedman · National Institute On Deafness And Other Communication Disorders · ZIA · FY2025 · DC

Mechanisms of dopamine neuron degeneration

$2,212,850
Robert E Burke · Columbia University Health Sciences · P50 · FY2012 · NS

The Immunobiology of Marrow Allografts for Leukemia

$2,212,710
Sloan-Kettering Institute For Cancer Res · P01 · FY2002 · CA

Intranasal Treatment of Stem Cell-derived Extracellular Vesicles for Alzheimer's Disease

$2,212,694
Ashok K. Shetty · Texas A&M University Health Science Ctr · RF1 · FY2022 · AG

Genetic and Signaling Pathways in Epithelial Thyroid Cancer

$2,212,542
Matthew D Ringel · Ohio State University · P01 · FY2013 · CA

Longitudinal Epigenomic Tracking of the Reprogramming Process

$2,212,538
Michael P Snyder · Stanford University · P01 · FY2014 · GM